Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRTC

Protech Inc

May 20 • 04:00PM ET

17.42

0.00 0.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: MCRB PLRX MREO RIGL ORIC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.60	Insider Own	-	Shs Outstand	24.34M	Perf Week	0.17%
Market Cap	424.03M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-1.91%
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	0.58%	Short Float	-	Perf Quarter	-1.08%
Income	-	P/S	91.01	EPS this Y	-	Inst Trans	-	Short Ratio	2.67	Perf Half Y	10.11%
Sales	4.66M	P/B	1.35	EPS next Y	-	ROA	-	Short Interest	0.02M	Perf YTD	4.69%
Book/sh	12.91	P/C	-	EPS next 5Y	-	ROE	-	52W High	19.92 -12.55%	Perf Year	-0.03%
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	14.50 20.14%	Perf 3Y	-30.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.75% 4.31%	Perf 5Y	-66.88%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-312.58%	Oper. Margin	-	ATR (14)	0.79	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-3.44%	Profit Margin	-	RSI (14)	51.77	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	0.51%	Beta	1.15	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-38.20%	SMA50	3.40%	Rel Volume	0.00	Prev Close	17.42
Employees	-	LT Debt/Eq	-	Earnings	Apr 29 BMO	SMA200	0.45%	Avg Volume	9.20K	Price	17.42
IPO	Nov 16, 2020	Option/Short	No / No	EPS/Sales Surpr.	6.86% -93.19%	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-24	Resumed	Leerink Partners	Outperform	$58 → $45

May-01-26 01:32PM	Seaport Therapeutics stock pops 17% on Nasdaq debut (Quartz) +5.16%
04:26AM	PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO (Proactive)
Apr-29-26 02:01AM	PureTech Announces Annual Results for Year Ended December 31, 2025 (Business Wire)
02:00AM	PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange (Business Wire)
Apr-27-26 02:22PM	Psychiatry Drugmaker Seaport Seeks $212.4 Million in US IPO (Bloomberg)
07:05AM	Loading…
07:05AM	PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors (Business Wire)
Apr-22-26 07:00AM	PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML) (Business Wire)
Apr-13-26 02:05AM	PureTech Health: Notice of Results (Business Wire) +7.91%
Apr-02-26 08:19AM	PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine (Business Wire)
07:08AM	PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo in Healthy Volunteers (Business Wire)
Mar-25-26 02:04PM	PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans (Business Wire)
Feb-25-26 02:00AM	PureTech to Present at the Leerink Partners Global Healthcare Conference (Business Wire)
Feb-19-26 12:36PM	PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis (Business Wire)
Jan-06-26 07:00AM	PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-18-25 02:00AM	PureTech Appoints Robert Lyne as Chief Executive Officer (Business Wire)
02:00AM	Loading…
Dec-08-25 02:00AM	PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis (Business Wire) -7.20%
Dec-05-25 01:00PM	PureTechs Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome (Business Wire) +7.50%
Nov-03-25 09:00AM	PureTechs Founded Entity Gallop Oncology to Present New Data from Ongoing Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia (AML) at the American Society of Hematology (ASH) Annual Meeting (Business Wire)
Oct-22-25 02:00AM	PureTech Presents New Phase 2b Analyses Demonstrating Consistent Safety and Efficacy of Deupirfenidone in Older Patients with Idiopathic Pulmonary Fibrosis (IPF), a Historically Undertreated Group (Business Wire)
Oct-01-25 08:02AM	Pres. Trump's deal with Pfizer is pretty devastating to PBMs and insurance companies: John Lamattina (CNBC TV)
Sep-16-25 12:00PM	What Makes PureTech Health (PRTC) a New Buy Stock (Zacks)
Sep-11-25 07:05AM	PureTech Founded Entity Seaport Therapeutics Advances Second Therapeutic Candidate into Clinical Development with Dosing of First Participant in Phase 1 Study of GlyphAgo (SPT-320) in Healthy Volunteers (Business Wire)
Aug-28-25 02:00AM	PureTech Health plc Half-Year Report (Business Wire)
Aug-21-25 07:00AM	PureTech Showcases Differentiated Development Strategy, Including New Patient Preference Insights, and Spotlights Phase 2b Data Positioning Deupirfenidone as a Potential New Standard of Care in IPF (Business Wire)
Aug-18-25 02:00AM	PureTech Health: Notice of Half-Yearly Results (Business Wire) +10.16%
Aug-13-25 12:16PM	PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint (Business Wire)
Aug-12-25 07:00AM	PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases (Business Wire)
Jul-17-25 07:05AM	PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress (Business Wire)
Jul-16-25 02:00AM	PureTech Announces Leadership Transition (Business Wire)
Jul-08-25 12:45PM	PureTech Announces Board Change (Business Wire)
02:00AM	Loading…
Jun-26-25 02:00AM	PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement (Business Wire) +5.53%
Jun-16-25 12:59PM	PureTech Health: Results of Annual General Meeting (Business Wire)
May-22-25 07:00AM	PureTech to Present at the Jefferies Global Healthcare Conference (Business Wire) +6.09%
May-20-25 05:15PM	PureTechs Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial (Business Wire)
May-09-25 07:00AM	PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF) (Business Wire)
May-02-25 09:00PM	PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ... (GuruFocus.com)
May-01-25 07:00AM	PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference (Business Wire)
Apr-30-25 07:56PM	PureTech Health plc (PRTC) Q4 2024 Earnings Call Transcript (Seeking Alpha)
02:00AM	PureTech Announces Annual Results for Year Ended December 31, 2024 (Business Wire)
Apr-23-25 02:00AM	PureTech Health: Notice of Results (Business Wire)
Apr-09-25 02:00AM	PureTech Appoints Peel Hunt as Joint UK Corporate Broker (Business Wire)
Apr-07-25 12:16PM	PureTech Health plc Statement Regarding Press Speculation (Business Wire)
Mar-11-25 07:05AM	PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair (Business Wire)
Feb-25-25 07:27AM	PureTech to Present at the Leerink Partners Global Healthcare Conference (Business Wire)
Feb-12-25 07:05AM	PureTech Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with GlyphTM Platform (Business Wire)
Jan-27-25 02:00AM	PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine (Business Wire)
Jan-10-25 07:15AM	PureTech announces receipt of FDA Fast Track Designation for LYT-200 in AML (TipRanks)
Jan-09-25 07:00AM	PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) (Business Wire)
Jan-08-25 07:00AM	PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) -6.28%
Jan-06-25 02:00AM	PureTech Appoints UBS as UK Corporate Broker (Business Wire)
Dec-16-24 11:41AM	PureTech's Lung Disease Candidate Slowed Lung Function Decline In Idiopathic Pulmonary Fibrosis Patients (Benzinga) +8.85%
02:00AM	PureTechs Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial (Business Wire)
Dec-11-24 07:05AM	PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024 (Business Wire)
Dec-09-24 02:00AM	PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting (Business Wire)
Nov-20-24 07:05AM	PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors (Business Wire)
Nov-18-24 04:49PM	AI-Powered Drug Development Led to This Recent Breakthrough (InvestorPlace) -5.57%
Nov-05-24 07:05AM	PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer (Business Wire)
Oct-30-24 07:00AM	PureTech to Present at Two Upcoming Investor Conferences (Business Wire)
Oct-21-24 07:40AM	PureTech thinks the hub-and-spoke startup model is still a good bet. If only investors agreed. (BioPharma Dive)
02:00AM	PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round (Business Wire)
Oct-09-24 06:44PM	Corrections & Amplifications (The Wall Street Journal)
02:00AM	PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting (Business Wire)
Oct-01-24 07:00AM	PureTech to Present at CHEST 2024 Annual Meeting (Business Wire) -5.31%
Sep-30-24 06:52AM	FDA approves PureTechs KarXT to treat schizophrenia in adults (Pharmaceutical Technology)
Sep-27-24 02:00AM	PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults (Business Wire)
Sep-06-24 02:00AM	PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies (Business Wire) -6.82%
Aug-28-24 02:01AM	PureTech Health plc Half-Year Report (Business Wire) -6.00%
Aug-22-24 02:00AM	PureTech Appoints Michele Holcomb, PhD, to Board of Directors (Business Wire)
Aug-21-24 02:00AM	PureTech Health: Notice of Half-Yearly Results (Business Wire)
Aug-13-24 07:05AM	PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors (Business Wire) +7.73%
Jul-23-24 08:26AM	PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial (Business Wire)
Jun-24-24 12:00PM	PureTech Health: Completion of Tender Offer & Total Voting Rights (Business Wire) -8.77%
02:00AM	PureTech Health: Results of the Tender Offer (Business Wire)
Jun-20-24 02:00AM	PureTech Announces Change of Board Role (Business Wire)
Jun-18-24 07:05AM	PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team (Business Wire)
Jun-13-24 01:15PM	PureTech Health: Results of Annual General Meeting (Business Wire)
Jun-06-24 12:38PM	PureTech Health: Result of General Meeting (Business Wire)
May-29-24 08:09AM	PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company (Business Wire)
May-23-24 07:00AM	PureTech to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-21-24 07:05AM	PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection (Business Wire)
May-20-24 06:35AM	PureTech Health Opens $100 Million Buyback Program (MT Newswires)
02:00AM	PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share (Business Wire)
May-09-24 07:05AM	PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting (Business Wire)
May-07-24 07:05AM	PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments (Business Wire)
Apr-30-24 08:37AM	PureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-25-24 05:22AM	PureTech Announces Annual Results for Year Ended December 31, 2023 (Business Wire)
Apr-18-24 02:00AM	PureTech Health: Notice of Results (Business Wire)
Apr-16-24 07:00AM	PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis (Business Wire)
Apr-11-24 07:00AM	PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers (Business Wire)
Apr-09-24 08:19AM	PureTech launches Seaport, hoping to create Karuna 2.0 (BioPharma Dive)
02:00AM	PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions (Business Wire)
Apr-02-24 08:50AM	PureTech Health (PRTC) is on the Move, Here's Why the Trend Could be Sustainable (Zacks) -7.37%
Mar-19-24 03:00AM	PureTech Proposes $100 Million Capital Return (Business Wire) +9.78%
Mar-18-24 09:52AM	Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion (Business Wire)
Mar-13-24 07:00AM	PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia (Business Wire)
Feb-27-24 07:00AM	PureTech to Present at Two Upcoming Investor Conferences (Business Wire)
02:00AM	PureTech Founded Entity Akili Announces Positive Results from Shionogis Phase 3 Clinical Trial of Localized Version of Akilis EndeavorRx for Pediatric ADHD Patients in Japan (Business Wire)
Feb-15-24 09:35AM	Down -8.13% in 4 Weeks, Here's Why PureTech Health PLC Sponsored ADR (PRTC) Looks Ripe for a Turnaround (Zacks) +5.67%
Jan-03-24 07:00AM	PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-22-23 09:13AM	PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion (Business Wire) +33.93%

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts.

L.L.B.Mr. Robert Lyne J.D.

Ph.D.Dr. Robert S. Langer Jr.

Co-Founder & PresidentDr. Eric Elenko Ph.D.

Co-Founder & Senior AdvisorDr. David R. Elmaleh Ph.D.

Chief Financial OfficerMs. Lauren A. White M.B.A.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRTC

Protech Inc

Upgrade your Finviz experience